Atlas Trials

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients

Clinical trial NCT02784756 · COMPLETED

Trial details

NCT number
NCT02784756
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cytomegalovirus Viraemia
Start date
2016-06-01
Primary completion
2020-02-01
Enrollment
134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.